CLINICAL_TRIALS
trial_result
· 2012-12-11
Clinical Trial Update: Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients [Phase 4]
Summary
Phase 4 trial evaluating symptom-adapted therapy with Nexium (esomeprazole) in gastroesophageal reflux disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: GERD | Phase 4 | Status: COMPLETED | Results posted: 2012-12-11